跳至主要内容
临床试验/CTRI/2017/08/009582
CTRI/2017/08/009582已完成4 期

A randomised, double blind, comparative clinical trial assessing the effectiveness and safety of dapsone 5% versus clindamycin 1% in the treatment of mild to moderate acne vulgaris - DCRCT

Medical College Kolkata0 个研究点目标入组 51 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
51

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Subjects of 12 to 40 years of age of either sex
  • 2.Mild to moderate acne: >= 2 but <= 30 total lesions - inflammatory (papules and pustules) and/or non-inflammatory (open and closed comedones)
  • 3.Lesions in the face which correspond to a baseline investigator global assessment (IGA) score of 2 or 3

排除标准

  • 1.Age <12 or >40
  • 2.Total lesion count < 2 or >30,
  • 3.Subjects regularly using any anti-acne medications in the last 30 days before study entry
  • 4.Severe acne: Subjects with nodulo-cystic lesions, acne conglobata, acne fulminans
  • 5.Pregnancy or intention of pregnancy and breastfeeding
  • 6.Patients with G6PD deficiency
  • 7.History of having taken any medication that could interact with dapsone (e.g. Trimetoprim-sulfametoxazol
  • 8.Known hypersensitivity to the study medication
  • 9.Patients not willing to comply with protocol requirements

研究者

相似试验